论文部分内容阅读
目的:观察布地奈德雾化吸入治疗急性咽喉炎的疗效。方法:选择急性咽喉炎66例,随机分观察组与对照组各33例,观察组采用布地奈德+庆大霉素+生理盐水雾化吸入治疗;对照组采用地塞米松+庆大霉素+靡蛋白酶+生理盐水雾化吸入治疗,比较两组疗效。结果:观察组和对照组治愈、好转、无效及总有效率分别为19例(57.6%)、12例(36.4%)、2例(6.0%)及93.9%,10例(30.3%)、14例(42.4%)、9例(27.3%)及72.7%,两组比较,差异显著(P<0.05)。观察组平均治疗1.5个疗程,对照组平均2个疗程。结论:布地奈德雾化吸入治疗急性咽喉炎疗效优于对照组,且疗程短。
Objective: To observe the efficacy of budesonide inhalation in the treatment of acute pharyngitis. Methods: A total of 66 cases of acute pharyngitis were randomly divided into observation group (33 cases) and control group (33 cases). The observation group was given budesonide + gentamicin + saline inhalation. The control group was treated with dexamethasone + gentamycin + Extravagant protease + saline inhalation therapy, the efficacy of the two groups were compared. Results: The cure, improvement, ineffectiveness and total effective rate in observation group and control group were 19 cases (57.6%), 12 cases (36.4%), 2 cases (6.0%) and 93.9%, 10 cases Cases (42.4%), 9 cases (27.3%) and 72.7%, the difference between the two groups was significant (P <0.05). The observation group average treatment of 1.5 courses, the control group an average of 2 courses. Conclusion: The efficacy of inhaled budesonide in the treatment of acute laryngopharyngitis is better than that of the control group, and the course of treatment is short.